Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Independent ethics committee curbs seen hurting Indian studies

This article was originally published in SRA

Executive Summary

Following on from the Supreme Court of India issuing strict time-bound instructions to the government concerning the regulatory regime for clinical trials, a new notice restricting the scope of activities of independent ethics committees (ECs) is expected to have a crushing impact on investigator-led and post-marketing studies in the country1.

You may also be interested in...

India Ethical Guidelines For Research: Pertinent – But Less May Be More?

India's draft revised ethical guidelines for biomedical and health research involving human participants covers a raft of new and existing segments. It expands on "specialized" areas such as "informed consent" and "vulnerability" – complex and delicate issues in the Indian context - but some experts say that the multiplicity of "overlapping" rules and guidelines could complicate compliance efforts.

India To Scrap Intellectual Property Appellate Board

Legal experts explain why India’s plans to abolish the Intellectual Property Appellate Board and shift its powers to courts may be problematic for stakeholders, including those pursuing infringement charges. The transition could mean a significant burden on courts both in terms of capability and capacity, and IPR cases will now conflate into all other pending commercial matters, some experts said, though others cheered the proposed change.

Creating Healthcare Unicorns: Ex-Novartis CFO Shares Secret Sauce

Ex-Novartis executive and co-founder of investment bank MM Dillon & Co shares insights around where healthcare unicorns can be found and some core criteria to build such firms.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts